(Q43691282)

25 November 2017

title

Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia (English)

1 reference

bronchopulmonary dysplasia

25 November 2017

main subject

1 reference

11

Parviz Minoo

1 reference

25 November 2017

Arlene Garingo

1

1 reference

25 November 2017

Linda Tesoriero

2

1 reference

25 November 2017

Rowena Cayabyab

3

1 reference

25 November 2017

Manuel Durand

4

1 reference

25 November 2017

Martin Blahnik

5

1 reference

25 November 2017

Smeeta Sardesai

6

1 reference

25 November 2017

Rangasamy Ramanathan

7

1 reference

25 November 2017

Craig Jones

8

1 reference

25 November 2017

Kenny Kwong

9

1 reference

25 November 2017

Changgong Li

10

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

25 November 2017

1 reference

25 November 2017

volume

61

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

197-202

1 reference

Bronchopulmonary dysplasia

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Lipopolysaccharide-induced tumor necrosis factor-alpha and IL-10 production by lung macrophages from preterm and term neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Differential regulation of IL-8 by IL-1beta and TNFalpha in hyaline membrane disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

NF-kappaB: a multifaceted transcription factor regulated at several levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

Stimulus-Specific Inhibition of IL-5 by cAMP-Elevating Agents and IL-10 Reveals Differential Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31802D8A1C

10.1203/PDR.0B013E31802D8A1C

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

1050326157

0 references

1 reference